These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28940220)

  • 21. Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients.
    Furiati SC; Catarino JS; Silva MV; Silva RF; Estevam RB; Teodoro RB; Pereira SL; Ataide M; Rodrigues V; Rodrigues DBR
    Sci Rep; 2019 May; 9(1):7526. PubMed ID: 31101850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.
    Suárez-Fariñas M; Ungar B; Noda S; Shroff A; Mansouri Y; Fuentes-Duculan J; Czernik A; Zheng X; Estrada YD; Xu H; Peng X; Shemer A; Krueger JG; Lebwohl MG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1277-87. PubMed ID: 26316095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Levels of Platelet-Lymphocyte Complexes in Patients with Psoriasis Are Associated with a Better Response to Anti-TNF-α Therapy.
    Sanz-Martínez MT; Moga E; Sánchez Martínez MA; Zamora Atenza C; Vidal S; Juárez C; Puig L
    J Invest Dermatol; 2020 Jun; 140(6):1176-1183. PubMed ID: 31778714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psoriasis or atopic eczema: skin-infiltrating effector memory T cells make the difference].
    Homey B
    Hautarzt; 2012 Jan; 63(1):52. PubMed ID: 22212158
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of TNF-alpha inhibitors on circulating Th17 cells in patients affected by severe psoriasis.
    Piaserico S; Sandini E; Saldan A; Abate D
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S73-6. PubMed ID: 25381985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.
    Darrigade AS; Milpied B; Truchetet ME; Schaeverbeke T; Laharie D; Zerbib F; Beylot-Barry M; Jouary T; Taïeb A; Ezzedine K; Seneschal J
    Acta Derm Venereol; 2017 Jun; 97(6):731-734. PubMed ID: 28218339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin under Tnf influence: how regulatory T cells work against macrophages in psoriasis.
    Gatzka M
    J Pathol; 2017 Jan; 241(1):3-5. PubMed ID: 27747869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-helper 22 cells as a new player in chronic inflammatory skin disorders.
    Mirshafiey A; Simhag A; El Rouby NM; Azizi G
    Int J Dermatol; 2015 Aug; 54(8):880-8. PubMed ID: 26183243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu.
    Niebuhr M; Baumert K; Heratizadeh A; Satzger I; Werfel T
    Allergy; 2014 Aug; 69(8):1058-67. PubMed ID: 24894535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis.
    Hvid H; Teige I; Kvist PH; Svensson L; Kemp K
    Int Immunol; 2008 Aug; 20(8):1097-106. PubMed ID: 18579711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
    Guttman-Yassky E; Krueger JG; Lebwohl MG
    Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.
    Quaglino P; Bergallo M; Ponti R; Barberio E; Cicchelli S; Buffa E; Comessatti A; Costa C; Terlizzi ME; Astegiano S; Novelli M; Cavallo R; Bernengo MG
    Dermatology; 2011; 223(1):57-67. PubMed ID: 21865674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris.
    Antiga E; Volpi W; Chiarini C; Cardilicchia E; Filì L; Manuelli C; Parrochi P; Fabbri P; Caproni M
    Int J Immunopathol Pharmacol; 2010; 23(3):767-74. PubMed ID: 20943046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?
    Joyau C; Veyrac G; Dixneuf V; Jolliet P
    Clin Exp Rheumatol; 2012; 30(5):700-6. PubMed ID: 22935567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.
    Bosè F; Raeli L; Garutti C; Frigerio E; Cozzi A; Crimi M; Caprioli F; Scavelli R; Altomare G; Geginat J; Abrignani S; Reali E
    Clin Immunol; 2011 May; 139(2):164-76. PubMed ID: 21334981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.
    Albanesi C; Scarponi C; Cavani A; Federici M; Nasorri F; Girolomoni G
    J Invest Dermatol; 2000 Jul; 115(1):81-7. PubMed ID: 10886512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review.
    Grinblat B; Scheinberg M
    Semin Arthritis Rheum; 2008 Feb; 37(4):251-5. PubMed ID: 17640718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The panoply of αβT cells in the skin.
    Nomura T; Kabashima K; Miyachi Y
    J Dermatol Sci; 2014 Oct; 76(1):3-9. PubMed ID: 25190363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.
    Brunner PM; Glitzner E; Reininger B; Klein I; Stary G; Mildner M; Uhrin P; Sibilia M; Stingl G
    Exp Dermatol; 2015 Jul; 24(7):522-8. PubMed ID: 25828150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α.
    Langkilde A; Olsen LC; Sætrom P; Drabløs F; Besenbacher S; Raaby L; Johansen C; Iversen L
    PLoS One; 2016; 11(12):e0167437. PubMed ID: 28005985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.